Cargando…
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
BACKGROUND: Solitary Fibrous Tumour (SFT) is a rare soft tissue neoplasm, described in several locations in the body. It is classified as intermediate malignant potential with low risk of metastasis and has a low tendency to recur after primary surgery. METHODS: We performed a prospective data colle...
Autores principales: | Maruzzo, Marco, Martin-Liberal, Juan, Messiou, Christina, Miah, Aisha, Thway, Khin, Alvarado, Rolyn, Judson, Ian, Benson, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320530/ https://www.ncbi.nlm.nih.gov/pubmed/25664166 http://dx.doi.org/10.1186/s13569-015-0022-2 |
Ejemplares similares
-
Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis
por: Martin-Liberal, Juan, et al.
Publicado: (2013) -
Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital
por: Thanopoulou, Eirini, et al.
Publicado: (2015) -
Treatment of Epithelioid Sarcoma at the Royal Marsden Hospital
por: Livi, L., et al.
Publicado: (2003) -
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program
por: Kollàr, Attila, et al.
Publicado: (2014) -
Pazopanib, a promising option for the treatment of aggressive fibromatosis
por: Szucs, Zoltan, et al.
Publicado: (2017)